Developer docs
API playgroundTry for free, no card

Search company profiles

Precision Diagnostics

Full company profile

uuid00097ra

Namestring
Precision Diagnostics
Legal namestring
Precision Diagnostics, LLC
Company typeenum
Private
Founded yearint
2013
Descriptiontext

Precision Diagnostics, LLC is a privately held clinical reference laboratory founded in 2013 and headquartered in San Diego, California, with a secondary laboratory in Dartmouth, Massachusetts. The company provides next-generation urine and oral fluid drug testing services to healthcare providers across the United States, targeting physicians, pain management specialists, addiction treatment providers, and primary care providers. The company self-identifies as 'The Fastest Growing Company in the Industry' on its careers page and employs 251-500 staff.

Short descriptiontext

Precision Diagnostics is a clinical reference laboratory providing LC-MS/MS urine and oral fluid drug testing, DNA specimen authentication, and drug-drug interaction intelligence to U.S. healthcare providers serving pain management and addiction treatment practices.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersSan Diego, United States
HQ citystring
San Diego
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical laboratory services, drug testing services, LC-MS/MS diagnostics, urine drug testing, specimen authentication
Industry2 codes
PRIMARYHLAFAMAJ
Reference & Esoteric Testing Laboratories
SECONDARYHLAFAMAE
Molecular Diagnostics & Genomics Laboratories
NAICS code2 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories6215
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Clinical Laboratory Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Clinical Laboratory Testing Services
TypeSubscription Recurring
Description

Precision Diagnostics operates as a clinical reference laboratory providing diagnostic testing services to healthcare providers. Revenue is generated through billable laboratory tests, with payments received from payers including health insurance plans and potentially government healthcare programs. Services include urine drug testing, oral fluid drug testing, DNA specimen verification, and drug-drug interaction reporting. The company aligns with value-based care principles and focuses on medically necessary test utilization.

precisiondxlab.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 4 records shown
1VerifID
Description

DNA matching solution that verifies patient identity by matching urine specimen to donor patient for error-free care and sample authenticity.

precisiondxlab.com
+3 more records
Core offering1 text field

Precision Diagnostics is a clinical reference laboratory providing next-generation urine and oral fluid drug testing for healthcare providers. The company operates two laboratories (San Diego, CA and Dartmouth, MA) and delivers four integrated offerings: VerifID DNA specimen authentication, NextGen research-grade LC-MS/MS testing with optimized cutoffs, UpNEXT HIPAA-compliant scheduling and management platform, and DDI drug-drug interaction intelligence powered by Elsevier's Gold Standard Drug Database. Services are billed to payers and ordered by physicians, pain management specialists, addiction treatment centers, and primary care providers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Analysis of 46,000+ anonymized patient results demonstrated that conventional cutoff levels produced false negatives, representing missed opportunities for intervention and strained provider-patient relationships
Product overview1 text field

Precision Diagnostics offers a suite of four integrated clinical laboratory products focused on urine and oral fluid drug testing. The portfolio includes VerifID (DNA specimen authentication), NextGen (advanced LC-MS/MS testing with optimized cutoffs), UpNEXT (drug testing management and scheduling), and DDI (drug-to-drug interaction intelligence). These products work together to provide comprehensive drug testing services with a focus on accuracy, patient safety, and provider efficiency.

Product and service1 record
1VerifID
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Elsevier (Gold Standard Drug Database)
Strategic tierCoreTypeTechnology or Integration
Description

Elsevier's Gold Standard Drug Database (GSDD) provides the drug interaction descriptions that power Precision DDI. This integration enables healthcare providers to access trusted drug-to-drug interaction intelligence as a complimentary enhancement across all formats of Precision's test reports. The DDI data is seamlessly integrated into test reports within the clinical workflow, enabling confident decision-making without disruption.

precisiondxlab.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
1U.S. Drug Testing Laboratories
TypeDirect peer
Description

Specialty laboratory focused on forensic and clinical drug testing including urine toxicology; comparable to Precision's specialty focus on drug monitoring for healthcare and judicial clients.

TypeDirect peer
Description

Specialty clinical laboratory focused on urine drug testing and medication monitoring using LC-MS/MS; closest direct competitor to Precision's NextGen product, serving pain management and addiction treatment providers.

TypeBroad incumbent
Description

International clinical laboratory operator with U.S. presence providing diagnostic testing including toxicology; comparable to Precision as a reference lab serving healthcare providers.

TypeDirect peer
Description

Clinical reference laboratory offering specialized diagnostics including toxicology and drug monitoring; comparable to Precision in serving specialty testing needs of healthcare providers.

TypeBroad incumbent
Description

Largest U.S. clinical reference laboratory offering a broad menu including drug testing; competes with Precision Diagnostics on national scale, payer contracts, and logistics rather than on LC-MS/MS specialization.

TypeBroad incumbent
Description

Global clinical diagnostics and testing services group operating reference laboratories; competes in specialty clinical testing markets including toxicology relevant to Precision Diagnostics.

TypeBroad incumbent
Description

Major U.S. clinical lab with full-service drug testing offerings and deep payer relationships; overlaps with Precision in urine drug screening but competes primarily on breadth and integration.

TypeDirect peer
Description

Major U.S. reference laboratory offering esoteric and specialized testing including toxicology; comparable as a clinical reference lab with hospital and physician clients and similar advanced analytical technology stack.

TypeDirect peer
Description

Clinical laboratory providing medication monitoring and drug testing services to healthcare providers, including pain and behavioral health — directly comparable offering to Precision Diagnostics.

TypeEmerging player
Description

Specialty laboratory offering hair-based drug testing for workplace, legal, and clinical monitoring; adjacent to Precision's urine/oral fluid focus with overlap in addiction and pain-management provider segments.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Precision Diagnostics

Clinical Laboratory Servicesprecisiondxlab.com

Precision Diagnostics is a clinical reference laboratory providing LC-MS/MS urine and oral fluid drug testing, DNA specimen authentication, and drug-drug interaction intelligence to U.S. healthcare providers serving pain management and addiction treatment practices.

What Precision Diagnostics does

Precision Diagnostics, LLC is a privately held clinical reference laboratory founded in 2013 and headquartered in San Diego, California, with a secondary laboratory in Dartmouth, Massachusetts. The company provides next-generation urine and oral fluid drug testing services to healthcare providers across the United States, targeting physicians, pain management specialists, addiction treatment providers, and primary care providers. The company self-identifies as 'The Fastest Growing Company in the Industry' on its careers page and employs 251-500 staff.

Precision Diagnostics firmographics

Firmographics
Name
Precision Diagnostics
Legal name
Precision Diagnostics, LLC
Website
https://precisiondxlab.com
Company type
Private
Founded year
2013
Operating status
Operating
Headcount range
251–500 employees
Short description
Precision Diagnostics is a clinical reference laboratory providing LC-MS/MS urine and oral fluid drug testing, DNA specimen authentication, and drug-drug interaction intelligence to U.S. healthcare providers serving pain management and addiction treatment practices.
Ownership category
akta.pro rank

Precision Diagnostics industry classification

Industry
Product category
Clinical Laboratory Services
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)
SIC
Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAFAMAJ
Reference & Esoteric Testing Laboratories
SECONDARYHLAFAMAE
Molecular Diagnostics & Genomics Laboratories

Keywords

  • Clinical laboratory services
  • Drug testing services
  • LC-MS/MS diagnostics
  • Urine drug testing
  • Specimen authentication

Where Precision Diagnostics is headquartered

Location

Headquarters

HQ city
San Diego
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Precision Diagnostics business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Clinical Laboratory Testing Services: Precision Diagnostics operates as a clinical reference laboratory providing diagnostic testing services to healthcare providers. Revenue is generated through billable laboratory tests, with payments received from payers including health insurance plans and potentially government healthcare programs. Services include urine drug testing, oral fluid drug testing, DNA specimen verification, and drug-drug interaction reporting. The company aligns with value-based care principles and focuses on medically necessary test utilization.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Precision Diagnostics product offering

Product offering

Core offering

Precision Diagnostics is a clinical reference laboratory providing next-generation urine and oral fluid drug testing for healthcare providers. The company operates two laboratories (San Diego, CA and Dartmouth, MA) and delivers four integrated offerings: VerifID DNA specimen authentication, NextGen research-grade LC-MS/MS testing with optimized cutoffs, UpNEXT HIPAA-compliant scheduling and management platform, and DDI drug-drug interaction intelligence powered by Elsevier's Gold Standard Drug Database. Services are billed to payers and ordered by physicians, pain management specialists, addiction treatment centers, and primary care providers.

Product overview

Precision Diagnostics offers a suite of four integrated clinical laboratory products focused on urine and oral fluid drug testing. The portfolio includes VerifID (DNA specimen authentication), NextGen (advanced LC-MS/MS testing with optimized cutoffs), UpNEXT (drug testing management and scheduling), and DDI (drug-to-drug interaction intelligence). These products work together to provide comprehensive drug testing services with a focus on accuracy, patient safety, and provider efficiency.

Differentiator

Problem solved

Functional benefit

Brands

  • VerifID: DNA matching solution that verifies patient identity by matching urine specimen to donor patient for error-free care and sample authenticity.
  • NextGen
  • UpNEXT
  • DDI

Products and services

  • VerifID

Quantifiable outcome

  • Analysis of 46,000+ anonymized patient results demonstrated that conventional cutoff levels produced false negatives, representing missed opportunities for intervention and strained provider-patient relationships

Companies that use Precision Diagnostics

Customer profile

Segments3 records

Ideal customer profiles2 records

Precision Diagnostics technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

Feature4 records

Precision Diagnostics partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Elsevier (Gold Standard Drug Database)coreTechnology or IntegrationElsevier's Gold Standard Drug Database (GSDD) provides the drug interaction descriptions that power Precision DDI. This integration enables healthcare providers to access trusted drug-to-drug interaction intelligence as a complimentary enhancement across all formats of Precision's test reports. The DDI data is seamlessly integrated into test reports within the clinical workflow, enabling confident decision-making without disruption.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Precision Diagnostics competitors and assessment

Company assessment

Direct peers

  • U.S. Drug Testing Laboratories: Specialty laboratory focused on forensic and clinical drug testing including urine toxicology; comparable to Precision's specialty focus on drug monitoring for healthcare and judicial clients.
  • Millennium Health: Specialty clinical laboratory focused on urine drug testing and medication monitoring using LC-MS/MS; closest direct competitor to Precision's NextGen product, serving pain management and addiction treatment providers.
  • BioReference Health (formerly BioReference Laboratories): Clinical reference laboratory offering specialized diagnostics including toxicology and drug monitoring; comparable to Precision in serving specialty testing needs of healthcare providers.
  • ARUP Laboratories: Major U.S. reference laboratory offering esoteric and specialized testing including toxicology; comparable as a clinical reference lab with hospital and physician clients and similar advanced analytical technology stack.
  • Aegis Sciences Corporation: Clinical laboratory providing medication monitoring and drug testing services to healthcare providers, including pain and behavioral health — directly comparable offering to Precision Diagnostics.

Broad incumbents

  • Sonic Healthcare USA: International clinical laboratory operator with U.S. presence providing diagnostic testing including toxicology; comparable to Precision as a reference lab serving healthcare providers.
  • Quest Diagnostics: Largest U.S. clinical reference laboratory offering a broad menu including drug testing; competes with Precision Diagnostics on national scale, payer contracts, and logistics rather than on LC-MS/MS specialization.
  • Eurofins Scientific: Global clinical diagnostics and testing services group operating reference laboratories; competes in specialty clinical testing markets including toxicology relevant to Precision Diagnostics.
  • Laboratory Corporation of America (LabCorp): Major U.S. clinical lab with full-service drug testing offerings and deep payer relationships; overlaps with Precision in urine drug screening but competes primarily on breadth and integration.

Emerging players

  • Psychemedics Corporation: Specialty laboratory offering hair-based drug testing for workplace, legal, and clinical monitoring; adjacent to Precision's urine/oral fluid focus with overlap in addiction and pain-management provider segments.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Precision Diagnostics social profiles

Digital presence

Precision Diagnostics compliance and trust

Trust signal

Compliance4 records

Precision Diagnostics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Precision Diagnostics leadership team

Management profile

Number of profiles

Profiles9 records

Precision Diagnostics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Precision Diagnostics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Precision Diagnostics

What does Precision Diagnostics do?

Precision Diagnostics is a clinical reference laboratory providing next-generation urine and oral fluid drug testing for healthcare providers. The company operates two laboratories (San Diego, CA and Dartmouth, MA) and delivers four integrated offerings: VerifID DNA specimen authentication, NextGen research-grade LC-MS/MS testing with optimized cutoffs, UpNEXT HIPAA-compliant scheduling and management platform, and DDI drug-drug interaction intelligence powered by Elsevier's Gold Standard Drug Database. Services are billed to payers and ordered by physicians, pain management specialists, addiction treatment centers, and primary care providers.

Is Precision Diagnostics a public or private company?

Precision Diagnostics is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Precision Diagnostics founded?

Precision Diagnostics was founded in 2013. It employs 251 to 500 people.

Where is Precision Diagnostics based?

Precision Diagnostics is headquartered in San Diego, United States, in the North America region.

How does Precision Diagnostics make money?

One revenue line is on record: clinical Laboratory Testing Services.

Who are Precision Diagnostics's main competitors?

Direct peers on record are U.S. Drug Testing Laboratories, Millennium Health, BioReference Health (formerly BioReference Laboratories), ARUP Laboratories and Aegis Sciences Corporation. Broad incumbents are Sonic Healthcare USA, Quest Diagnostics, Eurofins Scientific and Laboratory Corporation of America (LabCorp). Psychemedics Corporation is listed as an emerging player.

Does Precision Diagnostics have an API?

No public API is recorded for Precision Diagnostics.

What industry is Precision Diagnostics in?

Precision Diagnostics's product category is Clinical Laboratory Services. Its primary akta.pro industry code is HLAFAMAJ, Reference & Esoteric Testing Laboratories, with a secondary code of HLAFAMAE, Molecular Diagnostics & Genomics Laboratories. Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswirePrecision Diagnostics Publishes Groundbreaking Whitepaper on DNA-Based Urine Specimen Verification, Advancing Accuracy and Patient Experience in Toxicology TestingPrecision Diagnostics announced the publication of a whitepaper on its VerifID solution, a DNA-based urine specimen verification technology that uses short tandem repeat (STR) analysis to confirm patient identity in drug testing. The technology aims to replace traditional observation-based specimen validity testing, offering a more trauma-informed and patient-centered approach. The company positions this innovation as addressing longstanding tradeoffs between patient dignity and test integrity in behavioral health and substance use disorder treatment settings.Coherent Market InsightsPrecision Diagnostics Market Size & Opportunities, 2026-2033The global precision diagnostics market is projected to grow from USD 108.15 billion in 2026 to USD 257.61 billion by 2033, representing a compound annual growth rate of 13.2%, driven by technological advancements in genomics, molecular diagnostics, and bioinformatics. Key developments in 2025 include strategic partnerships between companies like Thermo Fisher Scientific and Illumina for NGS-based companion diagnostics, new product launches from Roche, Qiagen, and Siemens Healthineers, and Bio-Rad Laboratories' acquisition of Curiosity Diagnostics to expand its microfluidics platform. Despite growth drivers, the market faces headwinds from stringent government regulations and high development costs, while reimbursement challenges continue to limit adoption in low- and middle-income regions.openPR.comPrecision Diagnostics Market Generated Opportunities, Future Scope By 2032 | SomaLogic, Ezra, Egnite, PrecisionLifeThe precision diagnostics market is projected to grow from USD 95.54 billion in 2025 to USD 224.90 billion by 2032, a CAGR of 13.0%. The report highlights key players including SomaLogic, Ezra, Egnite, and PrecisionLife, and covers segmentation by product, technology, application, and region.PR NewswirePrecision Diagnostics Announces Major Enhancements to UpNext, the Industry-Leading Drug Testing Management SystemPrecision Diagnostics announced enhancements to its UpNext drug testing management system, including automated scheduling, protocol customization, and elimination of color line randomization. The updates reduce administrative burden and improve patient experience, with turnaround times of 24-48 hours. The company states UpNext is now the most advanced patient-centered drug testing solution.MorningstarPrecision Diagnostics announces the launch of VerifID, a groundbreaking solution that redefines sample authenticationPrecision Diagnostics launched VerifID, a sample authentication solution for drug testing that eliminates observed sample collection. The solution supports LGBTQIA+ inclusivity and trauma-informed care, aiming to improve diagnostic reliability and patient care.YahooPrecision Diagnostics announces the launch of VerifID, a groundbreaking solution that redefines sample authenticationPrecision Diagnostics launched VerifID, a sample authentication solution for drug testing that eliminates observed sample collection. The solution supports LGBTQIA+ inclusivity and trauma-informed care, aiming to improve diagnostic reliability and patient comfort.PR NewswireCOVID-19: Pandemic-related Stressors Place a Substantial Burden on the Vulnerable Population and Healthcare ProvidersPrecision Diagnostics, a U.S. laboratory specializing in clinical drug testing, launched UpNEXT, a virtual waiting room platform, to support healthcare providers in safely treating patients during the COVID-19 pandemic. Since its launch, the platform has facilitated over 5,000 patient visits and enrolled more than 90 providers, addressing increased mental health challenges and relapse rates among patients with substance use disorders. The company positions UpNEXT as a tool to reduce administrative burden and exposure risk while supporting addiction treatment, pain management, and primary care practices.PR NewswireCOVID-19: Precision Diagnostics Offers a Virtual Waiting Room for Providers to Safely Treat PatientsPrecision Diagnostics launched UpNEXT, a virtual waiting room solution designed to help healthcare providers safely treat patients during the COVID-19 pandemic. The platform offers remote check-in, mobile alerts, and administrative support to reduce exposure risk while maintaining efficient patient care. All UpNEXT consultations and support are being provided virtually and free of charge to qualifying healthcare practices.